Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It …
Medical - Diagnostics & Research
US, Wilmington [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 35.70 | 33.95 | 35.20 | 34.71 | 33.88 | 36.42 | 38.96 | 38.46 | 37.81 | 37.07 | 36.56 | 36.72 | 37.70 | 36.79 | 36.39 | |
| Profit Margin | 9.52 | -29.70 | 9.59 | 8.61 | 8.82 | 9.76 | 10.95 | 9.20 | 6.64 | 9.99 | 9.61 | 12.46 | 11.04 | 12.23 | 11.49 | |
| Operating Margin | 13.88 | -26.34 | 15.25 | 14.68 | 12.99 | 13.69 | 15.14 | 14.12 | 15.48 | 14.62 | 13.40 | 14.80 | 16.66 | 16.37 | 14.95 | |
|
EPS Growth
|
122.55 | -407.43 | 140.15 | -6.02 | 5.91 | 26.51 | 18.02 | 2.49 | -20.97 | 81.54 | 9.53 | 42.17 | 5.71 | 23.17 | -3.14 | |
| EPS USD | 175.00 | -538.00 | 216.00 | 203.00 | 215.00 | 272.00 | 321.00 | 329.00 | 260.00 | 472.00 | 517.00 | 735.00 | 777.00 | 957.00 | 927.00 | |
| Return on Assets (ROA) | 5.19 | -19.42 | 7.03 | 6.13 | 6.25 | 6.72 | 7.22 | 5.71 | 4.21 | 5.87 | 5.37 | 6.63 | 5.57 | 6.40 | 5.79 | |
| Return on Equity (ROE) | 8.33 | -48.98 | 20.78 | 16.19 | 16.04 | 18.85 | 20.37 | 18.50 | 11.80 | 17.18 | 15.42 | 17.23 | 15.42 | 16.34 | 13.20 | |
| Return on Invested Capital (ROIC) | 6.56 | -21.50 | 12.19 | 10.29 | 8.84 | 8.96 | 10.06 | 8.02 | 5.55 | 8.95 | 8.06 | 8.32 | 8.97 | 8.41 | 7.18 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 22.36 | 40.43 | 46.07 | 42.02 | 40.36 | 41.26 | 41.72 | 45.54 | 39.08 | 43.26 | 42.71 | 38.89 | 41.56 | 41.40 | 42.80 | |
| Debt/Equity | 35.87 | 101.95 | 136.14 | 110.94 | 103.56 | 115.72 | 117.73 | 147.59 | 109.57 | 126.62 | 122.63 | 100.98 | 115.17 | 105.75 | 97.52 | |
| Debt/EBITDA | 160.52 | 426.67 | 330.97 | 302.90 | 300.14 | 303.42 | 323.00 | 382.24 | 266.59 | 358.92 | 313.72 | 248.15 | 326.54 | 290.36 | 270.28 | |
|
Debt/Capitalization
|
26.40 | 50.48 | 57.65 | 52.59 | 50.87 | 53.64 | 54.07 | 59.61 | 52.28 | 55.87 | 55.08 | 50.24 | 53.52 | 51.40 | 49.37 | |
| Long-Term Debt/Capitalization | 24.98 | 49.37 | 57.14 | 46.73 | 50.05 | 52.60 | 53.58 | 59.07 | 51.60 | 55.40 | 54.60 | 49.65 | 53.50 | 51.00 | 46.02 | |
| Interest Debt per Share USD | 7.87 | 11.75 | 14.94 | 14.61 | 14.34 | 16.94 | 18.89 | 26.86 | 24.74 | 36.12 | 42.38 | 44.84 | 59.52 | 63.11 | 71.14 | |
| Debt Growth | -14.45 | 42.21 | 2.44 | -7.16 | -0.41 | 17.19 | 10.95 | 43.10 | -7.28 | 45.67 | 20.17 | 6.53 | 36.71 | 6.10 | -1.00 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 238.46 | 212.83 | 196.42 | 141.78 | 223.67 | 204.92 | 179.38 | 152.90 | 178.34 | 160.84 | 143.81 | 143.03 | 123.32 | 131.83 | 152.47 | |
| Quick Ratio | 174.54 | 147.03 | 119.50 | 93.34 | 156.95 | 146.60 | 131.04 | 113.00 | 134.26 | 119.77 | 106.03 | 100.89 | 85.67 | 90.45 | 100.20 | |
| Cash Ratio | 73.10 | 68.97 | 31.78 | 32.05 | 63.12 | 54.03 | 37.83 | 27.38 | 35.34 | 35.01 | 33.51 | 27.20 | 23.35 | 21.43 | 26.23 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 752.69 | 746.44 | 796.40 | 833.56 | 862.04 | 926.52 | 887.83 | 1,079.76 | 1,004.98 | 1,115.03 | 1,035.05 | 996.47 | 1,107.49 | 982.53 | 690.81 | |
| Receivables Turnover | 610.60 | 587.35 | 618.28 | 556.42 | 528.27 | 502.99 | 504.80 | 461.87 | 431.98 | 479.85 | 509.93 | 473.33 | 550.67 | 528.46 | 529.16 | |
| Payables Turnover | 2,475.61 | 2,444.43 | 2,156.60 | 2,362.26 | 2,425.64 | 2,439.75 | 2,269.15 | 1,510.94 | 1,484.22 | 2,152.50 | 1,491.43 | 1,510.83 | 1,113.17 | 1,220.61 | 1,554.93 | |
|
Asset Turnover
|
54.56 | 65.39 | 73.33 | 71.20 | 70.87 | 68.83 | 65.91 | 62.00 | 63.40 | 58.77 | 55.86 | 53.25 | 50.40 | 52.30 | 50.39 | |
| Fixed Turnover | 138.90 | 150.59 | 154.82 | 157.53 | 172.37 | 191.74 | 201.09 | 222.46 | 237.55 | 242.91 | 221.35 | 224.47 | 223.49 | 214.06 | 203.04 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 769.88 | -875.58 | 422.73 | 497.17 | 722.02 | 1,486.78 | 1,369.75 | 856.83 | 965.50 | 519.64 | 576.77 | 500.65 | 798.08 | 1,097.93 | 451.51 | |
| Asset Coverage | 300 | 100 | 100 | 100 | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 200 | |
| Cash Flow Coverage (CFGR) | 45.66 | 24.12 | 28.59 | 31.19 | 31.21 | 32.27 | 33.18 | 24.16 | 27.62 | 26.45 | 23.99 | 25.60 | 26.06 | 19.69 | 19.50 | |
| EBITDA Coverage | 800 | 300 | 400 | 500 | 800 | 1,700 | 1,500 | 1,000 | 1,200 | 600 | 900 | 800 | 1,100 | 1,600 | 700 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 5.31 | -15.07 | 7.89 | 5.51 | 4.04 | 4.23 | 4.01 | 4.32 | 2.37 | 4.23 | 3.40 | 2.92 | 2.11 | 4.39 | 3.92 | |
|
Price/Earnings (P/E)
|
1,882.61 | -663.39 | 1,267.72 | 1,816.12 | 2,475.95 | 2,365.98 | 2,493.69 | 2,314.47 | 4,212.88 | 2,366.29 | 2,937.69 | 3,423.58 | 4,749.11 | 2,277.12 | 2,551.51 | |
| Price/Earnings Growth (PEG) | -15.36 | 1.63 | -9.05 | -301.76 | 418.85 | 89.24 | 138.43 | 928.68 | -200.87 | 29.02 | 308.13 | 81.19 | 831.09 | 98.30 | -813.93 | |
|
Price/Book (P/B)
|
156.82 | 324.90 | 263.38 | 294.10 | 397.20 | 445.94 | 507.92 | 428.08 | 497.26 | 406.63 | 452.93 | 589.81 | 732.52 | 372.00 | 336.68 | |
| Price/Tangible Book (P/TB) | 156.82 | 324.90 | 263.38 | 294.10 | 397.20 | 445.94 | 507.92 | 428.08 | 497.26 | 406.63 | 452.93 | 589.81 | 732.52 | 372.00 | 336.68 | |
| Price/Sales (P/S) | 179.16 | 197.05 | 121.56 | 156.44 | 218.44 | 231.00 | 273.12 | 213.03 | 279.76 | 236.38 | 282.45 | 426.56 | 524.50 | 278.46 | 293.26 | |
|
Price/Cash Flow (P/CF)
|
957.36 | 1,321.46 | 676.62 | 849.93 | 1,229.11 | 1,194.04 | 1,300.26 | 1,200.73 | 1,643.18 | 1,214.27 | 1,539.40 | 2,281.89 | 2,440.62 | 1,786.83 | 1,770.74 | |
| Price/Free CF (P/FCF) | 1,485.52 | 1,770.42 | 889.58 | 1,101.85 | 1,515.60 | 1,544.18 | 1,668.89 | 1,473.88 | 2,222.43 | 1,779.11 | 2,174.82 | 3,282.04 | 3,490.08 | 3,754.38 | 3,314.47 | |
| Price/Operating CF (P/OCF) | 957.36 | 1,321.46 | 676.62 | 849.93 | 1,229.11 | 1,194.04 | 1,300.26 | 1,200.73 | 1,643.18 | 1,214.27 | 1,539.40 | 2,281.89 | 2,440.62 | 1,786.83 | 1,770.74 |